"L’IRCCS Ospedale San Raffaele è una struttura clinica-scientifica-universitaria di rilievo internazionale e di alta specializzazione per diverse importanti patologie, riconosciuta nel 1972 “Istituto di Ricovero e Cura a Carattere Scientifico” (IRCCS). La tematica della Medicina Molecolare è sempre stata l’elemento caratterizzante di questa Istituzione che ha scelto di focalizzare verso la comprensione dei processi molecolari e le applicazioni mediche delle scoperte della biologia molecolare con lo scopo di sviluppare terapie innovative per le patologie del sistema nervoso centrale e periferico, dell’apparato cardiovascolare e del metabolismo, per le patologie tumorali, le malattie infettive e immunomediate, le malattie genetiche e rare."

During the past decade, San Raffaele Scientific Institute conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 2 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "San Raffaele Scientific Institute" #1 sponsor was "IRCCS San Raffaele" with 15 trials, followed by "Ospedale San Raffaele" with 6 trials sponsored, "Scientific Institute San Raffaele" with 6 trials sponsored, "Università Vita-Salute San Raffaele" with 5 trials sponsored and "Cytheris SA" with 5 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "San Raffaele Scientific Institute" #1 collaborator was "Italian Diabetes Foundation" with 2 trials as a collaborator, "Abbott Diagnostics Division" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Bucharest Emergency Hospital" with 1 trials as a collaborator and "Celgene Corporation" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "San Raffaele Scientific Institute" are "Pancreatic Cancer" (5 trials), "Diabetes Mellitus, Type 1" (4 trials), "Diffuse Large B-cell Lymphoma" (2 trials), "HIV-1 Infection" (2 trials) and "Hepatitis C" (2 trials). Many other conditions were trialed in "San Raffaele Scientific Institute" in a lesser frequency.

Most popular intervention types in "San Raffaele Scientific Institute" are "Drug" (30 trials), "Other" (8 trials), "Procedure" (7 trials), "Biological" (4 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Methotrexate" (3 trials), "Rituximab" (3 trials), "Thiotepa" (3 trials) and "Interleukin-7" (2 trials). Other intervention names were less common.

The vast majority of trials in "San Raffaele Scientific Institute" are 52 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "San Raffaele Scientific Institute". undefined are not yet recruiting, 11 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in San Raffaele Scientific Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in San Raffaele Scientific Institute, 4 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".